肾移植受者COVID-19感染:发病率与临床结局
在巴黎两家医院随访的1216例肾移植受者中,66例(5%)发生COVID-19,高于法国一般人群的0.3%。非白人种族、肥胖、哮喘及慢性肺病、糖尿病与COVID-19发病独立相关;COVID-19相关死亡率在总体人群为1%,在COVID-19阳性患者中为24%。
要点
- 肾移植受者COVID-19发病率5%,高于法国一般人群的0.3%。
- 非白人种族、肥胖、哮喘/慢性肺病、糖尿病与COVID-19发病独立相关。
- COVID-19相关死亡率在阳性患者中达24%,总体人群为1%。
核心结论
- 肾移植受者COVID-19发病风险及死亡风险较高,非白人种族及肥胖、糖尿病、哮喘和慢性肺病等合并症与发病风险升高独立相关。
研究设计与样本
- 2020年3月1日在巴黎两家医院接受随访的肾移植患者纳入研究,随访至2020年4月30日,共1216例。
主要发现
- 1216例中66例(5%)发生COVID-19,高于法国一般人群的0.3%。
- COVID-19阳性患者平均年龄56.4±12.5岁,37例(56%)为男性。
- 非白人种族(OR 2.17;95%CI 1.23–3.78;P=0.007)与COVID-19发病独立相关。
- 肥胖(OR 2.19;95%CI 1.19–4.05;P=0.01)、哮喘及慢性肺病(OR 3.09;95%CI 1.49–6.41;P=0.002)与COVID-19发病独立相关。
- 糖尿病(OR 3.33;95%CI 1.92–5.77;P<0.001)与COVID-19发病独立相关;COVID-19相关死亡率总体人群1%、阳性患者24%。
临床怎么用
- 对肾移植受者中的非白人种族及合并肥胖、糖尿病、哮喘或慢性肺病者,应加强COVID-19防控与监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COVID-19 has been associated with high morbidity and mortality in kidney transplant recipients. However, risk factors for COVID-19 disease in patients with kidney transplants remain poorly defined. METHODS: We enrolled patients who underwent kidney transplantation and were actively followed up in two hospitals in Paris on March 1st, 2020. Patients were screened for baseline and transplant characteristics, functional parameters, comorbidities, and immunosuppressive therapies. COVID-19 disease was assessed. Patients were followed up during the pandemic until April 30th, 2020 by the COVID-19 SLS KT survey program, including teleconsulting, at-home monitoring for patients with COVID-19, and a dedicated phone hotline platform. RESULTS: Among 1216 patients with kidney transplants enrolled, 66 (5%) patients were identified with COVID-19 disease, which is higher than the incidence observed in the general population in France (0.3%). Their mean age was 56.4±12.5 years, and 37 (56%) patients were men. The following factors were independently associated with COVID-19 disease: non-White ethnicity (adjusted odds ratio [OR], 2.17; 95% confidence interval [95% CI], 1.23 to 3.78; P=0.007), obesity (OR, 2.19; 95% CI, 1.19 to 4.05; P=0.01), asthma and chronic pulmonary disease (OR, 3.09; 95% CI, 1.49 to 6.41; P=0.002), and diabetes (OR, 3.33; 95% CI, 1.92 to 5.77; P<0.001). The mortality rate related to COVID-19 disease was 1% in the overall study population and 24% in COVID-19-positive patients. CONCLUSIONS: Patients with kidney transplants display a high risk of mortality. Non-White ethnicity and comorbidities such as obesity, diabetes, asthma, and chronic pulmonary disease were associated with higher risk of developing COVID-19 disease. It is imperative that policy makers urgently ensure the integration of such risk factors on response operations against COVID-19.
引用
- Elias M, Pievani D, Randoux C, et al. COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes. J Am Soc Nephrol. 2020. PMID: 32847984. doi:10.1681/ASN.2020050639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。